ETP on Saxo Healthcare Innovation Select Equity NTR 129209210 / CH1292092108
17.33
CHF
-0.42
CHF
-2.36 %
13:04:46
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 17.60 CHF | 0.07 CHF | 0.39 % |
|---|
| Vortag | 17.53 CHF | Datum | 29.05.2026 |
ETP on Saxo Healthcare Innovation Select Equity NTR Kurs - 1 Jahr
Anzeige
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 121.36% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 120.29% | |
| 21Shares Injective Staking ETP | CH1360612134 | 100.57% | |
| 21Shares Artificial Superintelligence Alliance ETP | CH1480821375 | 46.70% | |
| 21Shares Ondo ETP | CH1396389921 | 38.01% | |
| 21Shares Bittensor ETP | CH1495416971 | 37.33% | |
| 21Shares Render ETP | CH1396343266 | 37.28% | |
| 21Shares Jupiter ETP | CH1480821383 | 15.15% | |
| 21Shares Pendle ETP | CH1495416997 | 7.79% | |
| 21Shares Dogecoin ETP | CH1431521033 | 4.38% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 74.76% | |
| 21shares Canton Network ETP | CH1503127917 | 69.53% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 29.47% | |
| 21Shares Toncoin Staking ETP | CH1297762812 | 6.62% | |
| 21Shares Render ETP | CH1396343266 | 4.74% | |
| 21Shares Injective Staking ETP | CH1360612134 | -0.80% | |
| 21Shares Bittensor ETP | CH1495416971 | -20.37% | |
| 21Shares Jupiter ETP | CH1480821383 | -30.82% | |
| 21Shares Dogecoin ETP | CH1431521033 | -36.55% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -40.19% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | 13.18% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -6.38% | |
| 21Shares Binance BNB ETP | CH0496454155 | -7.65% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -22.65% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | -23.34% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -33.72% | |
| 21Shares Dogecoin ETP | CH1431521033 | -52.40% | |
| 21Shares Injective Staking ETP | CH1360612134 | -55.48% | |
| 21Shares Immutable ETP | CH1360612142 | -73.86% | |
| 21Shares Sui Staking ETP | CH1360612159 | -74.03% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 137.66% | |
| 21Shares Stellar ETP | CH1109575535 | 86.33% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 65.24% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 22.18% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 7.57% |
Fundamentaldaten
| Valor | 129209210 |
| ISIN | CH1292092108 |
| Emittent | LEONTEQ SECURITIES |
| Aufgelegt in | Switzerland |
| Auflagedatum | 30.09.2025 |
| Kategorie | Branchen: Biotechnologie |
| Währung | CHF |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 28.05.2026 |
Anlagepolitik
So investiert der ETP on Saxo Healthcare Innovation Select Equity NTR: The objective of this instrument is to provide exposure to companies advancing biotechnology, genomics, and personalised healthcare solutions. The selection includes firms engaged in genetic research, diagnostics, life-science tools, and innovative biopharmaceutical development. The instrument seeks to reflect the long-term potential of healthcare innovation as a driver of improved medical outcomes and industry transformation. Returns may be influenced by regulatory decisions, clinical results, ethical considerations, and market conditions.
ETP Performance: ETP on Saxo Healthcare Innovation Select Equity NTR
| Performance 1 Jahr | - | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |